Submission of proceedings of the 33rd Annual General Meeting pursuant to regulations 30 of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015

BSE Limited Date: 28 September 2026 Corporate Relationship Department P.J. Towers, Dalal Street Mumbai – 400001 Scrip Code: 530313 Security ID: KIMIABL Subject: Proceedings of the 33rd Annual General Meeting pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 30 read with Para A(13) of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the proceedings of the 33rd Annual General Meeting (“AGM”) of Kimia Biosciences Limited (“Company”) held on Monday, 28 September 2026 at 3:10 P.M. (IST) through Video Conferencing/Other Audio Visual Means (“VC/OAVM”), in accordance with the applicable provisions of Companies Act, 2013 and Rules Made there under, the Securities Exchange Board of India (SEBI) (Listing Obligations and Disclosures Requirements) Regulations 2015 and relevant circulars issued by the MCA and SEBI. In this regard please find the enclosed summary of the proceedings of the annual General Meeting (AGM) pursuant to the Regulations 30 of the SEBI (LODR) Regulations 2015 alongwith the circulars issued thereunder as Annexure – I. The above information will also be made available on the website of the Company at www.kimiabiosciences.com.. You are requested to take above on record Your faithfully For Kimia Biosciences Limited Abhishek Kumar Pandey (Company Secretary & Compliance Officer) M. No. : F12457 Place- Gurugram compliance.kimiabiosciences@gmail.com | info@kimiabiosciences.com | www.kimiabiosciences.com | CIN No.:L24239HR1993PLC032120 ”ANNEXURE – I” Summary of the proceedings of the Annual General Meeting (“AGM or Meeting”) of the Company Meeting Details: The Annual General Meeting of the Members of the Company was held on Monday, September 28", 2026 through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM). The Meeting commenced at 3:10 p.m. (IST). The meeting was conducted in accordance with the relevant Circulars issued by the Ministry of Corporate Affairs (“MCA”) and the Securities Exchange Board of India (“SEBI”) in this regard. Mr. Abhishek Kumar Pandey, Company Secretary & Compliance Officer welcomed the members to the meeting and briefed them on certain important points relating to the participation at the meeting and voting of Annual General Meeting (AGM). Chairman: Mr. Sameer Goel, Managing Director and CEO of the Company chaired the meeting in compliance with the circulars issued by the Ministry of Corporate Affairs, Government of India and Securities and Exchange Board of India. He presided over the Meeting as Chairperson in terms of the Articles of Association of the Company. Quorum: With the permission of the Chairperson, the Company Secretary confirmed the presence of requisite quorum as required under Section 103 of the Companies Act, 2013 at the commencement of the Meeting through Video Conferencing to conduct the proceedings of the meeting and also ensured that the quorum was also present while transacting the business items of the Meeting. Thereafter, the Company Secretary provided general instructions to the Shareholders participating in the Meeting. He mentioned that the Notice convening the Annual General Meeting (AGM), had already been sent to the Shareholders in the prescribed manner and through prescribed mode. He also informed the Shareholders regarding availability of all the relevant documents as referred in the Annual General Meeting (AGM) Notice for inspection during the Annual General Meeting (AGM). compliance.kimiabiosciences@gmail.com | info@kimiabiosciences.com | www.kimiabiosciences.com | CIN No.:L24239HR1993PLC032120 E-voting During the Meeting: The Shareholders attending the Meeting, who had the right to vote but had not cast their votes through remote e-Voting were given the opportunity to vote using the e- voting platform of NSDL at the conclusion of the meeting. The Company Secretary thereafter begin with the proceedings of the meeting. Proceedings of the meeting: In reference to the briefing provided, following items as stated in the Notice of Annual General Meeting (AGM) were taken for consideration of members: Item Type Particulars of Resolution 1 Ordinary To receive, consider and adopt the Audited Financial Statements for the year ended 31st March 2026, along with the Reports of the Directors’ and Auditors’ thereon. 2 Ordinary To appoint a director in place of Mr. Sameer Goel (DIN: 00161786), Director, who retires by rotation, and being eligible,offers himself for re-appointment pursuant to the provisions of Section 152 of the Companies Act, 2013. 3 Ordinary To approve the remuneration of the Cost Auditors for the financial year ending 31st March, 2026. 4 Ordinary To approve appointment of Mr. Amulya Kumar Nayak (DIN: 11667557) as Director retire by rotation. 5 Ordinary To approve appointment of Ms. Reema Goyal (DIN: 11266730) as Independent & Non-Executive Woman Director 6 Ordinary To approve appointment of Mr. Avinash Prabhat (DIN:10997441) as Independent & Non-Executive Director. 7 Special Approval for increasing the borrowing limit under section 180(1) (c) of the Companies Act, 2013 8 Special To create mortgage and/or charge on all or any of the movable and/or immovable properties of the company 9 Special Approval of loans, investments, guarantee or security u/s 185 of Companies Act, 2013 10 Special Approval of Members for increase in the limits applicable for making investments / extending loans and giving guarantees or providing securities in connection with loans to Persons / Bodies Corporate u/s 186 of the Companies Act,2013. compliance.kimiabiosciences@gmail.com | info@kimiabiosciences.com | www.kimiabiosciences.com | CIN No.:L24239HR1993PLC032120 Then, with the permission of Chairman Company Secretary commenced the Question & Answer (Q&A) session. Thereafter moderator announced that the Company had received a request from pre- registered speaker shareholders, Mr. Pramod Jain to participate in the Annual General Meeting (AGM) as a speaker. Upon due verification and in accordance with the process communicated in the notice, Mr.Pramod Jain was allowed to express views and raise questions during the meeting. He appreciated the overall performance of the Company and expressed satisfaction over the efforts of the Board and management in ensuring transparency, stakeholder engagement, and business continuity. The aforesaid resolutions were placed before the Members for consideration and voting. The Scrutinizer will submit the consolidated Scrutinizer’s Report after completion of the e-voting process. The voting results together with the Scrutinizer’s Report shall be submitted to BSE Limited and hosted on the website of the Company within the time prescribed under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The AGM concluded at 3:30 P.M. with a vote of thanks to the Chair. For Kimia Biosciences Limited Abhishek Kumar Pandey Company Secretary & Compliance Officer M. No. F12457 Place- Gurugram. compliance.kimiabiosciences@gmail.com | info@kimiabiosciences.com | www.kimiabiosciences.com | CIN No.:L24239HR1993PLC032120